HNK20 monoclonal IgA antibody: Began Phase I trial

By WIR Staff | May 16, 1994 | 7:00 AM GMT

OraVax Inc., Cambridge, Mass.
Product:

Read the full 52 word article

How to gain access

Continue reading with a
two-week free trial.